Job Opportunity: Post Doc Research Associate working with Tian Zhao and Mallat_Lab identifying the immunological mechanisms underlying atherosclerosis ➡️ jobs.cam.ac.uk/job/45969/ Closes: 28 April 2024 #postdoc | #jobs | #research | VPD Heart & Lung Research Institute | Cambridge University

🚨 New Review Alert! 🚨 Check out our latest review on therapeutic targets to modulate B cells in humans, highlighting current and potential new therapies JF Mallat_Lab, Ziad Mallat, Tian Zhao, James O'Brien ahajrnls.org/4ci3N49

Studying or working in Cardiovascular Research? Then why not come along to our next Seminar where we will be hearing about Immune Dysregulation in Cardiovascular Disease: From Novel Mechanisms to Therapeutic Targeting with Pasquale Maffia

#papworthauthors new publication: Evaluation of microcirculatory protection in percutaneous revascularisation: A stent implantation technique and device comparison. doi.org/10.1002/ccd.31… #coronaryphysiology Tian Zhao Kitty Paques Bharat Khialani MBBS MPH MMed FRACP FESC FSCAI Royal Papworth Hospital NHS FT 💙 Royal Papworth Hospital Research Dept.

Amazing results of the IVORY trial Rouchelle Sriranjan Rothwell Joseph Cheriyan, James Rudd Stephen Hoole Tian Zhao Mallat_Lab Medical Research Council British Heart Foundation Cambridge University Royal Papworth Hospital NHS FT 💙 VPD Heart & Lung Research Institute CambridgeCardio National Institute for Health and Care Research @NHS Cambridge University Hospitals NHS and all IVORY team. 🙏 to the patients who have taken part!

Check our paper in nature nature.com/articles/s4158… This is a huge collaborative work combining great basic and clinical science, with important implications for the prevention of atherosclerotic cardiovascular disease. Thanks to all our collaborators and funders!

Consider lowering cholesterol ‘much earlier on in life’, researchers suggest independent.co.uk/news/health/nh…

What is cholesterol and how can we lower it? | The Independent independent.co.uk/life-style/hea…

eur03.safelinks.protection.outlook.com/?url=https%3A%…

High cholesterol levels at a young age significant risk factor for atherosclerosis | University of Cambridge cam.ac.uk/research/news/…

Research| Case et al. report that low-dose interleukin-2 clonally expands Tregs and maintains their suppressive program by bypassing BACH2 downregulation in patients with acute coronary syndrome from the LILACS trial.Mallat_Lab Tian Zhao Ziad Mallat rdcu.be/ephaW